Cargando…

Do we need to demonstrate Amyloid in tissue?

Detalles Bibliográficos
Autor principal:	Magy, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642101/ http://dx.doi.org/10.1186/1750-1172-10-S1-I13

Ejemplares similares

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Headache research - where are we heading?
por: Jensen, Rigmor
Publicado: (2013)

Myths, need, contribution to the diagnosis
por: Bozzao, Alessandro
Publicado: (2015)

Early exposure hypothesis: where are we now?
por: Lack, Gideon
Publicado: (2011)

Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

PReS13-SPK-1582: Activity and damage - we have to measure them
por: Feldman, BM
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

Why do experts on ectodermal dysplasia (ED) meet again?
por: Bergendal, Birgitta
Publicado: (2012)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Soft tissue handling and dental implant treatment
por: Neukam, Friedrich Wilhelm
Publicado: (2012)

Biotech Eucalyptus can sustainably address society’s need for wood: the example of freeze tolerant Eucalyptus in the southeastern U.S
por: Hinchee, Maud, et al.
Publicado: (2011)

Large-scale identification of tissue-specific enhancers in vivo
por: Pennacchio, Len A
Publicado: (2010)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

Thalassemias: can we reduce the national burden?
por: Colah, Roshan
Publicado: (2014)

I-2 Can we bypass a muscle metabolic defect?
por: Argov, Z.
Publicado: (2011)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Functional neuroimaging: the adaptive mechanisms in migraine
por: Tedeschi, Gioacchino, et al.
Publicado: (2015)

Neural plasticity and migraine
por: Coppola, Gianluca
Publicado: (2015)

Cortical spreading depression and familial hemiplegic migraine 2015
por: Pietrobon, Daniela
Publicado: (2015)

Non invasive neurostimulation
por: Grazzi, Licia
Publicado: (2015)

Obesity, diet and nutraceuticals
por: Di Lorenzo, Cherubino, et al.
Publicado: (2015)

Pathogenesis of chronic migraine: the role of neuromodulators
por: D'Andrea, Giovanni
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_804m2adrjlgiv6gf9vlhnn542f